Manfred Hallschmid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Manfred Hallschmid has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Jan Born
Institute for Medical Psychology and Behavioral Neurobiology, University of Tübingen, Tübingen, Germany
13 shared publications Andreas Fritsche
German Center for Diabetes Research (DZD) Tübingen Germany
7 shared publications- Hubert Preissl
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
7 shared publications Hendrik Lehnert
Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
4 shared publications- Niels Niethard
Institute of Medical Psychology and Behavioral Neurobiology, University of Tübingen, Tübingen, Germany
4 shared publications - Nils B. Kroemer
Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, University of Tübingen, Tübingen, Germany
4 shared publications
Latest Publications
- Open Access
- 23 January 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 63 (2) , e70401
Electrical Synapses Contribute to Sleep‐Dependent Declarative Memory Retention
Sleep supports memory formation by neurophysiological mechanisms that are yet to be fully uncovered. We investigated the contribution of the direct coupling of neurons via electrical synapses (gap junctions). The administration of mefloquine (250 mg p.o. vs. placebo), an antimalarial, which blocks electrical synapses, to healthy young men before nocturnal sleep impaired the retention of word pairs learned before drug administration and disrupted the coupling of sleep spindles to EEG slow oscillations. In control experiments, in which participants received mefloquine before a consolidation interval of nocturnal wakefulness or after rather than before sleep, word‐pair memory retention was not affected by the drug, suggesting that electrical synapses specifically support the sleep‐dependent retention of verbal declarative memory. Irrespective of sleep, mefloquine enhanced the retention of sensorimotor memory assessed with a finger sequence tapping task. In supplemental experiments in rats, mefloquine administered i.p. at escalating doses of 20 and 40 mg/kg did not alter hippocampal sharp‐wave/ripple activity, a prominent mechanism of hippocampal memory replay. While mefloquine effects beyond gap junctions in the present experiments cannot be fully excluded, we conclude that electrical coupling enhances the oscillatory coordination between sleep spindles and slow oscillations and, thereby, supports systems memory consolidation.
- 23 January 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 63 (2) , e70401
Open AccessElectrical Synapses Contribute to Sleep‐Dependent Declarative Memory Retention
Sleep supports memory formation by neurophysiological mechanisms that are yet to be fully uncovered. We investigated the contribution of the direct coupling of neurons via electrical synapses (gap junctions). The administration of mefloquine (250 mg p.o. vs. placebo), an antimalarial, which blocks electrical synapses, to healthy young men before nocturnal sleep impaired the retention of word pairs learned before drug administration and disrupted the coupling of sleep spindles to EEG slow oscillations. In control experiments, in which participants received mefloquine before a consolidation interval of nocturnal wakefulness or after rather than before sleep, word‐pair memory retention was not affected by the drug, suggesting that electrical synapses specifically support the sleep‐dependent retention of verbal declarative memory. Irrespective of sleep, mefloquine enhanced the retention of sensorimotor memory assessed with a finger sequence tapping task. In supplemental experiments in rats, mefloquine administered i.p. at escalating doses of 20 and 40 mg/kg did not alter hippocampal sharp‐wave/ripple activity, a prominent mechanism of hippocampal memory replay. While mefloquine effects beyond gap junctions in the present experiments cannot be fully excluded, we conclude that electrical coupling enhances the oscillatory coordination between sleep spindles and slow oscillations and, thereby, supports systems memory consolidation.
- 18 December 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (3)
Inference, controls, and replication in the study of sleep and metabolism
- 18 December 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (3)
Inference, controls, and replication in the study of sleep and metabolism
- Open Access
- 23 October 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 59 (2) , 249-259
Oxytocin Effects on Food Stimulus Processing and Food Intake in Females With or Without Binge Eating Disorder
Objective: Binge eating disorder (BED) is maintained by increased food‐related incentive salience, which is reflected by an attentional bias for food. Oxytocin acutely attenuates this bias in patients with anorexia nervosa and reduces food intake in males with normal or increased body weight. However, results in individuals with BED have been inconclusive. We assessed the acute effect of oxytocin on food stimulus processing and reward‐driven eating behavior in females with or without BED in a double‐blind, placebo‐controlled cross‐over study. Method: Females with BED ( n = 48) and female control participants with overweight ( n = 46) or normal weight ( n = 40) received intranasal oxytocin (24 IU) and, respectively, placebo, after an overnight fast and a standardized breakfast. In participants with a natural menstrual cycle, sessions were scheduled during consecutive luteal phases. Participants completed a food‐related dot‐probe task with concurrent eye tracking and a bogus taste test measuring snack intake. Results: Oxytocin compared to placebo increased dwell time bias on food stimuli in the BED relative to the overweight control group, in which this effect was reversed. Contrary to our hypothesis, oxytocin increased calorie intake across groups. Exploratory analyses indicated that the latter effect focused on females taking hormonal contraception. Discussion: These results indicate disorder‐ and, respectively, sex‐specific effects of oxytocin on food‐related incentive salience and food intake and point to a role of oxytocin in binge eating pathology. They moreover suggest that sex hormones determine the acute effect of oxytocin on eating behavior in females.
- 23 October 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 59 (2) , 249-259
Open AccessOxytocin Effects on Food Stimulus Processing and Food Intake in Females With or Without Binge Eating Disorder
Objective: Binge eating disorder (BED) is maintained by increased food‐related incentive salience, which is reflected by an attentional bias for food. Oxytocin acutely attenuates this bias in patients with anorexia nervosa and reduces food intake in males with normal or increased body weight. However, results in individuals with BED have been inconclusive. We assessed the acute effect of oxytocin on food stimulus processing and reward‐driven eating behavior in females with or without BED in a double‐blind, placebo‐controlled cross‐over study. Method: Females with BED ( n = 48) and female control participants with overweight ( n = 46) or normal weight ( n = 40) received intranasal oxytocin (24 IU) and, respectively, placebo, after an overnight fast and a standardized breakfast. In participants with a natural menstrual cycle, sessions were scheduled during consecutive luteal phases. Participants completed a food‐related dot‐probe task with concurrent eye tracking and a bogus taste test measuring snack intake. Results: Oxytocin compared to placebo increased dwell time bias on food stimuli in the BED relative to the overweight control group, in which this effect was reversed. Contrary to our hypothesis, oxytocin increased calorie intake across groups. Exploratory analyses indicated that the latter effect focused on females taking hormonal contraception. Discussion: These results indicate disorder‐ and, respectively, sex‐specific effects of oxytocin on food‐related incentive salience and food intake and point to a role of oxytocin in binge eating pathology. They moreover suggest that sex hormones determine the acute effect of oxytocin on eating behavior in females.
- Open Access
- 7 June 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (11)
The influence of peripheral glucose on sleep brain oscillations
Study Objectives: Previous research indicates a coupling of sleep-associated brain activity to peripheral glucose levels, such that ripple activity, a sign of increased hippocampal memory processing, is followed within 10 min by a dip in peripheral glucose levels. Whether there is respective negative feedback to the brain of peripheral glucose levels, or associated metabolic signaling, during sleep is not clear. Methods: We tested the effects of systemic glucose administration as well as the effects of fasting (for 6 h vs. ad libitum feeding) on sleep and oscillatory signatures of memory processing during sleep, i.e. hippocampal ripples, cortical spindles and slow oscillations (SOs), using electroencephalography (EEG) from skull and local field potential recordings (LFP) from CA1 in male rats. Continuous monitoring of interstitial glucose concentrations in a subset of animals allowed the assessment of the temporal relationship between glucose fluctuations and oscillatory events. Results: Hippocampal ripples and sleep spindles were accompanied by a transient decrease in peripheral glucose concentration. Neither glucose injection nor prior fasting influenced the macro-architecture of sleep during the subsequent 6 hours. Glucose injection (vs. water) increased spindle density. Prior fasting, compared with ad libitum feeding, increased numbers of ripples, spindles, SOs and of co-occurring SO-spindle events. Fasting also influenced SO-spindle phase-amplitude coupling, such that spindles occurred later during the SO upstate in fasted animals compared to those with ad libitum food access. Conclusions: Our findings indicate a relatively tight-paced glucose-to-brain feedback loop during sleep that may affect memory processing in thalamocortical and hippocampal networks.
- 7 June 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (11)
Open AccessThe influence of peripheral glucose on sleep brain oscillations
Study Objectives: Previous research indicates a coupling of sleep-associated brain activity to peripheral glucose levels, such that ripple activity, a sign of increased hippocampal memory processing, is followed within 10 min by a dip in peripheral glucose levels. Whether there is respective negative feedback to the brain of peripheral glucose levels, or associated metabolic signaling, during sleep is not clear. Methods: We tested the effects of systemic glucose administration as well as the effects of fasting (for 6 h vs. ad libitum feeding) on sleep and oscillatory signatures of memory processing during sleep, i.e. hippocampal ripples, cortical spindles and slow oscillations (SOs), using electroencephalography (EEG) from skull and local field potential recordings (LFP) from CA1 in male rats. Continuous monitoring of interstitial glucose concentrations in a subset of animals allowed the assessment of the temporal relationship between glucose fluctuations and oscillatory events. Results: Hippocampal ripples and sleep spindles were accompanied by a transient decrease in peripheral glucose concentration. Neither glucose injection nor prior fasting influenced the macro-architecture of sleep during the subsequent 6 hours. Glucose injection (vs. water) increased spindle density. Prior fasting, compared with ad libitum feeding, increased numbers of ripples, spindles, SOs and of co-occurring SO-spindle events. Fasting also influenced SO-spindle phase-amplitude coupling, such that spindles occurred later during the SO upstate in fasted animals compared to those with ad libitum food access. Conclusions: Our findings indicate a relatively tight-paced glucose-to-brain feedback loop during sleep that may affect memory processing in thalamocortical and hippocampal networks.
- Open Access
- 23 February 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Regulation of peripheral glucose levels during human sleep
Studies in rats indicate that oscillatory signatures of memory processing during sleep, specifically hippocampal sharp wave-ripples, also regulate peripheral glucose concentration. Here, we examined whether there is a similar link between such signatures of memory processing and glucose regulation during sleep in healthy humans. We obtained polysomnographic recordings and continuous recordings of peripheral interstitial glucose levels (1 sample/minute) from 10 participants (5 females) during two consecutive nights. Temporal relationships between electroencephalography (EEG) events of interest and glucose levels were examined using cross-correlation functions and peri-event time histograms. Confirming the findings in rats, we found that sleep spindles, a core signature of sleep-dependent memory processing, were followed within 1–6 minutes by a robust decrease in glucose concentrations. By contrast, slow oscillation events hallmarking slow wave sleep were followed, with a lag of 5–11 minutes, by an increase in glucose levels. Transitions into rapid eye movement sleep were followed by a glucose decrease after 10–14 minutes, whereas awakenings and microarousals were linked to immediate glucose increases. These temporal relationships indicate a sleep-specific regulation of peripheral glucose concentrations that is linked to both signatures of sleep-dependent memory processing as well as the macro-architecture of sleep. They possibly reflect noradrenergic regulation of sympathetic activity via the brainstem locus coeruleus and may be of relevance in clinical conditions with concurrent disturbances of sleep and glucose regulation.
- 23 February 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Open AccessRegulation of peripheral glucose levels during human sleep
Studies in rats indicate that oscillatory signatures of memory processing during sleep, specifically hippocampal sharp wave-ripples, also regulate peripheral glucose concentration. Here, we examined whether there is a similar link between such signatures of memory processing and glucose regulation during sleep in healthy humans. We obtained polysomnographic recordings and continuous recordings of peripheral interstitial glucose levels (1 sample/minute) from 10 participants (5 females) during two consecutive nights. Temporal relationships between electroencephalography (EEG) events of interest and glucose levels were examined using cross-correlation functions and peri-event time histograms. Confirming the findings in rats, we found that sleep spindles, a core signature of sleep-dependent memory processing, were followed within 1–6 minutes by a robust decrease in glucose concentrations. By contrast, slow oscillation events hallmarking slow wave sleep were followed, with a lag of 5–11 minutes, by an increase in glucose levels. Transitions into rapid eye movement sleep were followed by a glucose decrease after 10–14 minutes, whereas awakenings and microarousals were linked to immediate glucose increases. These temporal relationships indicate a sleep-specific regulation of peripheral glucose concentrations that is linked to both signatures of sleep-dependent memory processing as well as the macro-architecture of sleep. They possibly reflect noradrenergic regulation of sympathetic activity via the brainstem locus coeruleus and may be of relevance in clinical conditions with concurrent disturbances of sleep and glucose regulation.
- Open Access
- 20 August 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (8) , e3002768
Slow-wave sleep drives sleep-dependent renormalization of synaptic AMPA receptor levels in the hypothalamus
According to the synaptic homeostasis hypothesis (SHY), sleep serves to renormalize synaptic connections that have been potentiated during the prior wake phase due to ongoing encoding of information. SHY focuses on glutamatergic synaptic strength and has been supported by numerous studies examining synaptic structure and function in neocortical and hippocampal networks. However, it is unknown whether synaptic down-regulation during sleep occurs in the hypothalamus, i.e., a pivotal center of homeostatic regulation of bodily functions including sleep itself. We show that sleep, in parallel with the synaptic down-regulation in neocortical networks, down-regulates the levels of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) in the hypothalamus of rats. Most robust decreases after sleep were observed at both sites for AMPARs containing the GluA1 subunit. Comparing the effects of selective rapid eye movement (REM) sleep and total sleep deprivation, we moreover provide experimental evidence that slow-wave sleep (SWS) is the driving force of the down-regulation of AMPARs in hypothalamus and neocortex, with no additional contributions of REM sleep or the circadian rhythm. SWS-dependent synaptic down-regulation was not linked to EEG slow-wave activity. However, spindle density during SWS predicted relatively increased GluA1 subunit levels in hypothalamic synapses, which is consistent with the role of spindles in the consolidation of memory. Our findings identify SWS as the main driver of the renormalization of synaptic strength during sleep and suggest that SWS-dependent synaptic renormalization is also implicated in homeostatic control processes in the hypothalamus.
- 20 August 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (8) , e3002768
Open AccessSlow-wave sleep drives sleep-dependent renormalization of synaptic AMPA receptor levels in the hypothalamus
According to the synaptic homeostasis hypothesis (SHY), sleep serves to renormalize synaptic connections that have been potentiated during the prior wake phase due to ongoing encoding of information. SHY focuses on glutamatergic synaptic strength and has been supported by numerous studies examining synaptic structure and function in neocortical and hippocampal networks. However, it is unknown whether synaptic down-regulation during sleep occurs in the hypothalamus, i.e., a pivotal center of homeostatic regulation of bodily functions including sleep itself. We show that sleep, in parallel with the synaptic down-regulation in neocortical networks, down-regulates the levels of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) in the hypothalamus of rats. Most robust decreases after sleep were observed at both sites for AMPARs containing the GluA1 subunit. Comparing the effects of selective rapid eye movement (REM) sleep and total sleep deprivation, we moreover provide experimental evidence that slow-wave sleep (SWS) is the driving force of the down-regulation of AMPARs in hypothalamus and neocortex, with no additional contributions of REM sleep or the circadian rhythm. SWS-dependent synaptic down-regulation was not linked to EEG slow-wave activity. However, spindle density during SWS predicted relatively increased GluA1 subunit levels in hypothalamic synapses, which is consistent with the role of spindles in the consolidation of memory. Our findings identify SWS as the main driver of the renormalization of synaptic strength during sleep and suggest that SWS-dependent synaptic renormalization is also implicated in homeostatic control processes in the hypothalamus.
- Open Access
- 8 August 2024
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (10) , 4562-4570
Oxytocin does not acutely improve glucose tolerance in men with type 2 diabetes
Aim: To assess oxytocin's acute glucoregulatory impact in men with type 2 diabetes in the context of our previous findings that oxytocin improves β‐cell responsivity in healthy men. Methods: In a double‐blind, crossover comparison, intranasal oxytocin (24 IU) and placebo, respectively, were administered to 25 fasted men with non‐insulin–treated type 2 diabetes (age ± standard error of the mean, 63.40 ± 1.36 years; body mass index, 27.77 ± 0.66 kg/m 2 ; HbA1c, 6.86% ± 0.08%; Homeostatic Model Assessment of Insulin Resistance (HOMA‐IR, 3.44 ± 0.39) 60 minutes before an oral glucose tolerance test (oGTT). Key outcomes were compared with previous results in men with normal weight or obesity. Results: Oxytocin compared with placebo increased plasma oxytocin concentrations and reduced the heart rate, but did not alter glucose metabolism in the 3 hours after oGTT onset (area under the curve, glucose, 2240 ± 80.5 vs. 2190 ± 69.5 mmol/L × min; insulin, 45 663 ± 4538 vs. 44 343 ± 4269 pmol/L × min; C‐peptide, 235 ± 5.1 vs. 231 ± 15.9 nmol/L × min). Conclusions: This outcome contrasts with the oxytocin‐induced attenuation of early postprandial glucose excursions in normal‐weight individuals, but is in line with the absence of respective effects in men with obesity. We conclude that insulin resistance in type 2 diabetes is associated with decreased sensitivity to the acute glucoregulatory effect of oxytocin in male individuals.
- 8 August 2024
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (10) , 4562-4570
Open AccessOxytocin does not acutely improve glucose tolerance in men with type 2 diabetes
Aim: To assess oxytocin's acute glucoregulatory impact in men with type 2 diabetes in the context of our previous findings that oxytocin improves β‐cell responsivity in healthy men. Methods: In a double‐blind, crossover comparison, intranasal oxytocin (24 IU) and placebo, respectively, were administered to 25 fasted men with non‐insulin–treated type 2 diabetes (age ± standard error of the mean, 63.40 ± 1.36 years; body mass index, 27.77 ± 0.66 kg/m 2 ; HbA1c, 6.86% ± 0.08%; Homeostatic Model Assessment of Insulin Resistance (HOMA‐IR, 3.44 ± 0.39) 60 minutes before an oral glucose tolerance test (oGTT). Key outcomes were compared with previous results in men with normal weight or obesity. Results: Oxytocin compared with placebo increased plasma oxytocin concentrations and reduced the heart rate, but did not alter glucose metabolism in the 3 hours after oGTT onset (area under the curve, glucose, 2240 ± 80.5 vs. 2190 ± 69.5 mmol/L × min; insulin, 45 663 ± 4538 vs. 44 343 ± 4269 pmol/L × min; C‐peptide, 235 ± 5.1 vs. 231 ± 15.9 nmol/L × min). Conclusions: This outcome contrasts with the oxytocin‐induced attenuation of early postprandial glucose excursions in normal‐weight individuals, but is in line with the absence of respective effects in men with obesity. We conclude that insulin resistance in type 2 diabetes is associated with decreased sensitivity to the acute glucoregulatory effect of oxytocin in male individuals.
- Open Access
- 18 July 2023
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (7) , 101123
A sweet spot for the sleeping brain: Linking human sleep physiology and glucoregulation
- 18 July 2023
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (7) , 101123
Open AccessA sweet spot for the sleeping brain: Linking human sleep physiology and glucoregulation
- Open Access
- 9 April 2022
- Published by Springer Nature in International Journal of Obesity
- Vol. 46 (7) , 1319-1327
The effect of intranasal insulin on appetite and mood in women with and without obesity: an experimental medicine study
Background/Objectives: Intranasal (IN) administration of insulin decreases appetite in humans, but the underlying mechanisms are unclear, and it is unknown whether IN insulin affects the food intake of women with obesity. Subjects/Methods: In a double-blind, placebo-controlled, crossover design, participants (35 lean women and 17 women with obesity) were randomized to receive 160 IU/1.6 mL of IN insulin or placebo in a counterbalanced order in the post prandial state. The effects of IN insulin on cookie intake, appetite, mood, food reward, cognition and neural activity were assessed. Results: IN insulin in the post prandial state reduced cookie intake, appetite and food reward relative to placebo and these effects were more pronounced for women with obesity compared with lean women. IN insulin also improved mood in women with obesity. In both BMI groups, IN insulin increased neural activity in the insula when viewing food pictures. IN insulin did not affect cognitive function. Conclusions: These results suggest that IN insulin decreases palatable food intake when satiated by reducing food reward and that women with obesity may be more sensitive to this effect than lean women. Further investigation of the therapeutic potential of IN insulin for weight management in women with obesity is warranted.
- 9 April 2022
- Published by Springer Nature in International Journal of Obesity
- Vol. 46 (7) , 1319-1327
Open AccessThe effect of intranasal insulin on appetite and mood in women with and without obesity: an experimental medicine study
Background/Objectives: Intranasal (IN) administration of insulin decreases appetite in humans, but the underlying mechanisms are unclear, and it is unknown whether IN insulin affects the food intake of women with obesity. Subjects/Methods: In a double-blind, placebo-controlled, crossover design, participants (35 lean women and 17 women with obesity) were randomized to receive 160 IU/1.6 mL of IN insulin or placebo in a counterbalanced order in the post prandial state. The effects of IN insulin on cookie intake, appetite, mood, food reward, cognition and neural activity were assessed. Results: IN insulin in the post prandial state reduced cookie intake, appetite and food reward relative to placebo and these effects were more pronounced for women with obesity compared with lean women. IN insulin also improved mood in women with obesity. In both BMI groups, IN insulin increased neural activity in the insula when viewing food pictures. IN insulin did not affect cognitive function. Conclusions: These results suggest that IN insulin decreases palatable food intake when satiated by reducing food reward and that women with obesity may be more sensitive to this effect than lean women. Further investigation of the therapeutic potential of IN insulin for weight management in women with obesity is warranted.